Pharmaceuticals

High Throughput Screening (HTS) Market Growth Projection: Expected to Surpass $38.34 Billion by 2030 at 8.7% CAGR

February 16, 2026February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the high throughput screening (hts) market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the High Throughput Screening (HTS) Market in 2026, and what figure is it projected to hit by 2030?

The high throughput screening (hts) market size has experienced significant growth over recent years. It is anticipated to increase from $25.26 billion in 2025 to $27.47 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. The expansion observed in the past can be credited to factors such as a rising demand for expedited drug discovery, innovations in assay technologies, an uptick in pharmaceutical R&D investments, the growing incorporation of robotics in laboratories, and the wider reach of contract research organizations.

The market for high throughput screening (hts) is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $38.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.7%. This growth during the forecast timeframe stems from factors such as the incorporation of AI and machine learning into hts, the proliferation of personalized medicine, increasing capital flowing into biotechnology startups, the widening of emerging markets, particularly in Asia-Pacific, and the advancement of multiplexed and label-free assay technologies. Key trends expected within the forecast period encompass the integration of high-throughput automation, the reduction in size of screening platforms, sophisticated detection technologies, the creation of multiplexed assays, and cloud-enabled data management systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

Which Drivers Are Affecting Market Participation In The High Throughput Screening (HTS) Market?

An anticipated increase in chronic disease prevalence is set to drive the expansion of the high-throughput screening (HTS) market. Chronic diseases are defined as health conditions that endure over an extended duration, usually exceeding three months. HTS facilitates the swift evaluation of numerous chemical compounds to identify promising drug candidates that target specific pathways or mechanisms associated with chronic diseases, crucial for their effective long-term management. As an illustration, the National Library of Medicine, a US government agency, reported in January 2023 that the population in the US aged 50 and above with at least one chronic condition is projected to reach 142.66 million by 2050. Consequently, the growing occurrence of chronic diseases will fuel the expansion of the high-throughput screening (HTS) market.

What Segment Categories Are Covered In The High Throughput Screening (HTS) Market?

The high throughput screening (hts) market covered in this report is segmented –

1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

Subsegments:

1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

How Are Emerging Trends Affecting The Progression Of The High Throughput Screening (HTS) Market?

Leading firms in the high-throughput screening market are creating cutting-edge products, including multimode plate readers, to provide enhanced features and improved service to their clientele. A multimode plate reader (MPR) serves as a sophisticated laboratory instrument utilized in high-throughput screening for the analysis of biological and chemical samples within microplates, achieving this by consolidating various detection modes for a wide range of assays onto one platform. For example, in February 2023, PerkinElmer Inc., a MedTech company based in the US, introduced its EnVision Nexus system. The EnVision Nexus system is recognized as the fastest and most sensitive multimode plate reader accessible, specifically engineered for rigorous high-throughput screening (HTS) applications to accelerate drug discovery initiatives. Utilizing its distinct technology, which encompasses dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, along with current reagent kits, this platform delivers unmatched assay flexibility, precision, speed, and sensitivity to researchers. Featuring convenient walkaway capabilities, including a plate stacker for 20 or 50 plates or complete automation and integration for nonstop 24/7 workflow operations, the EnVision Nexus system enables researchers to effectively screen millions of samples with exceptional efficiency.

Which Major Industry Participants Are Leading The High Throughput Screening (HTS) Market Growth?

Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The High Throughput Screening (HTS) Market?

North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized High Throughput Screening (HTS) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp

Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2026, By The Business Research Company

High Throughput Screening Hts Market Report 2026

https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

Carrier Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

Herg Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795